RxDoctor Payments Data

Jessica Lillie

Nurse Practitioner · Neenah, WINPI 1932100096

Payments from drug & device makers

$983in general payments, 2019–2025

Across 50 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$161
  • Sumitomo Pharma America, Inc.$159
  • Merck$88
  • Olympus America Inc.$52
  • Urogen Pharma, Inc.$43
  • Dendreon Pharmaceuticals LLC$42
  • plus $438 from 19 others

What the payments were for

  • Food & beverage$983100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$983 in reported general payments places this provider in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$55,561
Medicare patients
338
Services billed
931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron441$283,924
GemtesaVibegron172$114,164
Trospium Chloride ErTrospium Chloride68$14,772
Tamsulosin Hcl802$14,144
Mirabegron ErMirabegron20$11,713
Fosfomycin Tromethamine39$11,538
Finasteride385$5,347
Potassium Citrate ErPotassium Citrate41$4,099
Methenamine Hippurate34$3,815
Estradiol58$3,581
Solifenacin Succinate65$2,905
Darifenacin ErDarifenacin Hydrobromide18$2,303
Oxybutynin Chloride ErOxybutynin Chloride114$1,897
Tolterodine Tartrate ErTolterodine Tartrate12$1,617
Trospium Chloride25$1,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$14$283,924441 claims
Sumitomo Pharma America, Inc.Gemtesa$159$114,164172 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Neenah

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →